The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adoption of consolidative durvalumab among patients with locally advanced non-small cell lung cancer.
 
Vikram Jairam
No Relationships to Disclose
 
Saamir Pasha
Employment - IQVIA
 
Pamela R. Soulos
Consulting or Advisory Role - Target RWE
 
Sarah B. Goldberg
Consulting or Advisory Role - AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; Genzyme; Regeneron
Research Funding - Amgen (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
 
James B. Yu
Honoraria - Boston Scientific
Consulting or Advisory Role - Boston Scientific; Galera Therapeutics
 
Roy H. Decker
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; Regeneron
Speakers' Bureau - AstraZeneca
Research Funding - Merck
Travel, Accommodations, Expenses - Physicans' Education Resource
 
Cary Philip Gross
Research Funding - AstraZeneca (Inst); Genentech; Johnson & Johnson (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech (Inst)
 
Henry S. Park
Honoraria - RadOnc Questions